231 related articles for article (PubMed ID: 30424933)
21. The microbiome and MS: The influence of the microbiota on MS risk and progression-Session chair summary.
Katz Sand I; Baranzini SE
Mult Scler; 2018 Apr; 24(5):587-589. PubMed ID: 29498302
[No Abstract] [Full Text] [Related]
22. Research Uncovers How Commensal Bacteria Contribute to Multiple Sclerosis.
Hampton T
JAMA; 2018 Aug; 320(5):429-430. PubMed ID: 30087987
[No Abstract] [Full Text] [Related]
23. [Microbiota and multiple sclerosis].
Gerdes LA; Yoon H; Peters A
Nervenarzt; 2020 Dec; 91(12):1096-1107. PubMed ID: 33044577
[TBL] [Abstract][Full Text] [Related]
24. Interrelation of Diet, Gut Microbiome, and Autoantibody Production.
Petta I; Fraussen J; Somers V; Kleinewietfeld M
Front Immunol; 2018; 9():439. PubMed ID: 29559977
[TBL] [Abstract][Full Text] [Related]
25. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
[TBL] [Abstract][Full Text] [Related]
26. Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.
Stanisavljević S; Dinić M; Jevtić B; Đedović N; Momčilović M; Đokić J; Golić N; Mostarica Stojković M; Miljković Đ
Front Immunol; 2018; 9():942. PubMed ID: 29770137
[TBL] [Abstract][Full Text] [Related]
27. Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis.
Stanisavljević S; Lukić J; Momčilović M; Miljković M; Jevtić B; Kojić M; Golić N; Mostarica Stojković M; Miljković D
Benef Microbes; 2016 Jun; 7(3):363-73. PubMed ID: 26839070
[TBL] [Abstract][Full Text] [Related]
28. Multiple sclerosis: Possibility of a gut environment-induced disease.
Sato W; Yamamura T
Neurochem Int; 2019 Nov; 130():104475. PubMed ID: 31152766
[TBL] [Abstract][Full Text] [Related]
29. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
Yadav SK; Ito K; Dhib-Jalbut S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
[TBL] [Abstract][Full Text] [Related]
30. Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis.
Brown J; Quattrochi B; Everett C; Hong BY; Cervantes J
Mult Scler; 2021 May; 27(6):807-811. PubMed ID: 32507072
[TBL] [Abstract][Full Text] [Related]
31. [Multiple sclerosis and microbiota. From genome to metagenome?].
Hohlfeld R; Wekerle H
Nervenarzt; 2015 Aug; 86(8):925-33. PubMed ID: 26099498
[TBL] [Abstract][Full Text] [Related]
32. Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis.
Maglione A; Zuccalà M; Tosi M; Clerico M; Rolla S
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440354
[TBL] [Abstract][Full Text] [Related]
33. Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology.
Sonner JK; Keil M; Falk-Paulsen M; Mishra N; Rehman A; Kramer M; Deumelandt K; Röwe J; Sanghvi K; Wolf L; von Landenberg A; Wolff H; Bharti R; Oezen I; Lanz TV; Wanke F; Tang Y; Brandao I; Mohapatra SR; Epping L; Grill A; Röth R; Niesler B; Meuth SG; Opitz CA; Okun JG; Reinhardt C; Kurschus FC; Wick W; Bode HB; Rosenstiel P; Platten M
Nat Commun; 2019 Oct; 10(1):4877. PubMed ID: 31653831
[TBL] [Abstract][Full Text] [Related]
34. The gut microbiota perspective for interventions in MS.
Zoledziewska M
Autoimmun Rev; 2019 Aug; 18(8):814-824. PubMed ID: 31176875
[TBL] [Abstract][Full Text] [Related]
35. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J
Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698
[TBL] [Abstract][Full Text] [Related]
36. Feeding the gut microbiome: impact on multiple sclerosis.
Bronzini M; Maglione A; Rosso R; Matta M; Masuzzo F; Rolla S; Clerico M
Front Immunol; 2023; 14():1176016. PubMed ID: 37304278
[TBL] [Abstract][Full Text] [Related]
37. The gut-brain connection: triggering of brain autoimmune disease by commensal gut bacteria.
Wekerle H
Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii68-ii75. PubMed ID: 27856664
[TBL] [Abstract][Full Text] [Related]
38. The gut microbiome and microbial translocation in multiple sclerosis.
Mirza A; Mao-Draayer Y
Clin Immunol; 2017 Oct; 183():213-224. PubMed ID: 28286112
[TBL] [Abstract][Full Text] [Related]
39. Serotoninergic system targeting in multiple sclerosis: the prospective for pathogenetic therapy.
Melnikov M; Sviridova A; Rogovskii V; Oleskin A; Boziki M; Bakirtzis C; Kesidou E; Grigoriadis N; Boykо A
Mult Scler Relat Disord; 2021 Jun; 51():102888. PubMed ID: 33756440
[TBL] [Abstract][Full Text] [Related]
40. Th17 Cells in MS and Experimental Autoimmune Encephalomyelitis.
Hofstetter H; Gold R; Hartung HP
Int MS J; 2009 Apr; 16(1):12-8. PubMed ID: 19413921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
